Many other ALK fusion proteins have since been described in different cancer forms, such as non‐small‐cell lung cancer, diffuse large B‐cell lymphoma (DLBCL) and inflammatory myofibroblastic tumour (IMT) (Hallberg & Palmer, 2013; Umapathy et al, 2019). Here, ALK is linked to cancer.